Corticosteroids Remain Common Treatment for RA
The discovery of corticosteroids at Mayo Clinic earned the Nobel Prize in 1950. A new Mayo study shows they are still a common treatment for rheumatoid arthritis, according to Mayo Clinic's Eric...
View ArticleGut Bacteria Hold Potential for Treating RA
Gut bacteria, specifically Prevotella histicola, have anti-inflammatory benefits that could help treat autoimmune disorders such as rheumatoid arthritis, according to Mayo Clinic rheumatologist Eric...
View ArticlePolymyalgia Rheumatica Symptoms, Treatment
Eric Matteson, M.D., a rheumatologist at Mayo Clinic in Rochester, Minn., talks about polymyalgia rheumatic, an autoimmune disease.
View ArticleMichelle Petri, MD, MPH; Minimizing the Burden of SLE
During this segment, Michelle Petri, MD, MPH, professor of medicine and director of the Lupus Center, Johns Hopkins University School of Medicine, explains how systemic lupus erythematosus burdens...
View ArticleACR: Perioperative management of DMARDs, biologics
SAN DIEGO -- Bernard Ng, MD, associate professor of medicine at VA Puget Sound Health Care System, presented research on perioperative management of disease-modifying antirheumatic drugs or biologic...
View ArticleFibromyalgia and Skin Disease
SAN DIEGO — Valerie Laniosz, MD, PhD, second-year dermatology resident at Mayo Clinic, Rochester, Minn., presented her research on the dermatologic manifestations of fibromyalgia at the American...
View ArticleTriple DMARD therapy analysis and discontinuation of therapy
SAN DIEGO -- Kaleb Michaud, PhD, assistant professor, University of Nebraska Medical Center, and co-director, National Data Bank for Rheumatic Diseases, discussed his research on combination...
View ArticleMichelle Petri, MD, MPH: Risk of diabetes in patients with lupus
SAN DIEGO -- Michelle Petri, MD, MPH, professor of medicine, Johns Hopkins University School of Medicine, Baltimore, presented research on the risk of diabetes in patients with lupus and the risk...
View ArticleUrate-lowering therapy reduced risk of kidney disease
SAN DIEGO -- Gerald Levy, MD, a rheumatologist with the Southern California Permanente Medical Group, presented research on the impact of urate-lowering therapy on kidney disease progression in...
View ArticleCombined guidelines for fibromyalgia from 3 countries
SAN DIEGO -- Mary-Ann Fitzcharles, MB, ChB, MD, clinical rheumatologist, McGill University, Montreal, presented results from the combination of guidelines for fibromyalgia from Canada, Israel and...
View ArticleEric Matteson, MD: Why RA patients are at higher risk for heart disease
SAN DIEGO -- Eric Matteson, MD, MPH, chair of the division of rheumatology, Mayo Clinic, Rochester, Minn., presented highlights of studies of patients with rheumatoid arthritis and the risk of...
View ArticleMichelle Petri, MD, MPH: Hydroxychloroquine levels in SLE patients
SAN DIEGO -- Michelle Petri, MD, MPH, professor of medicine at Johns Hopkins University School of Medicine, Baltimore, presented research on hydroxychloroquine levels in patients with systemic lupus...
View ArticleUse of medical marijuana for rheumatic conditions
SAN DIEGO -- Maryann Fitzcharles, MB, ChB, MD, presented an update on the use of medical marijuana for rheumatic conditions at the American College of Rheumatology annual meeting.
View ArticlePrevalence of Fibromyalgia in Elderly Women
SAN DIEGO -- Brian Walitt, MD, MPH, associate professor of medicine, Georgetown University, and attending physician, MedStar Washington Hospital Center, Washington, DC, presented results of a study on...
View ArticleDSM-5, somatoform disorders and fibromyalgia
SAN DIEGO -- Frederick Wolfe, MD, of the National Data Bank for Rheumatic Diseases, Wichita, Kan., presented results of a study on the 2013 Diagnostic and Statistical Manual of Mental Disorders...
View Article
More Pages to Explore .....